Abstract
Ophthalmic manifestations of inflammatory bowel disease are common, but orbital inflammatory disease is rare with most cases associated with Crohn disease. We describe the first case of bilateral, diffuse, orbital myositis associated with ulcerative colitis in a patient taking infliximab. Within 72 hours of intravenous methylprednisolone treatment, the orbital inflammation dramatically improved. After 8 weeks of prednisone, it completely resolved and has remained quiet for 13 months. This is only the third report of ulcerative colitis-associated orbital inflammatory disease.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies, Monoclonal / therapeutic use
-
Colitis, Ulcerative / complications*
-
Colitis, Ulcerative / drug therapy
-
Glucocorticoids / therapeutic use
-
Humans
-
Infliximab
-
Male
-
Methylprednisolone / therapeutic use
-
Middle Aged
-
Oculomotor Muscles / diagnostic imaging
-
Oculomotor Muscles / pathology
-
Orbital Myositis / diagnostic imaging
-
Orbital Myositis / drug therapy
-
Orbital Myositis / etiology*
-
Recurrence
-
Tomography, X-Ray Computed
Substances
-
Antibodies, Monoclonal
-
Glucocorticoids
-
Infliximab
-
Methylprednisolone